License Income means the gross amount actually received by either CERES or any AFFILIATED COMPANY in consideration for the grant of SUBLICENSES to SUBLICENSEES that are not AFFILIATED COMPANIES to produce and sell seed of the LICENSED VARIETIES, including up-front fees, lump sum payments and any running royalties on a product-by-product and jurisdiction-by-jurisdiction basis, without deduction of any kind.
License Income means the amount actually received by either LICENSEE or any AFFILIATED COMPANY in consideration for the grant of sublicenses to sublicensees that are not AFFILIATED COMPANIES to produce and sell LICENSED PRODUCTS, including up-front fees, lump sum payments and any other non-running royalty-based payments made on a product-by-product and jurisdiction-by-jurisdiction basis.
License Income means the amount actually received by either CERES or any AFFILIATED COMPANY in consideration for the grant of SUBLICENSES to SUBLICENSEES that are not AFFILIATED COMPANIES to produce and sell COMMERCIAL PROPAGULES of the LICENSED VARIETY, including up-front fees, lump sum payments and any running royalties on a product-by-product and jurisdiction-by-jurisdiction basis. *NOTE: definitions of NET SALES and LICENSE INCOME may vary in function of the business models that may be developed
Examples of License Income in a sentence
Any damages received by LICENSEE as a result of an enforcement action of rights to jointly owned INTELLECTUAL PROPERTY RIGHTS, after deduction of all enforcement related costs incurred by LICENSEE, shall be considered as NET SALES or LICENSE INCOME, as appropriate, for the purpose of remuneration payments to SYSTEM.
Where there is no identifiable LICENSE INCOME, a hypothetical fair market value price will be determined by the Parties jointly in good faith for the purpose of calculating LICENSE INCOME.
Royalties shall be payable by March 31 of each year with respect to the NET SELLING PRICE and LICENSE INCOME received by CERES and any AFFILIATED COMPANIES in the preceding calendar year.
Payments shall be made by check to the following address: Institute Secretary Institute of Grassland and Environmental Research Plas Gogerddan Xxxxxxxxxxx Xxxxxxxxxx XX00 0XX Xxxxxx Xxxxxxx Such payments shall be accompanied by a written report setting forth the production volumes and sales by CERES, and each SUBLICENSEE, of COMMERCIAL PROPAGULES during the calendar year, permitted exclusions, NET SALES, LICENSE INCOME and the royalties due.
Royalties shall be payable by March 31 of each year with respect to the NET SALES and LICENSE INCOME received by CERES and any AFFILIATED COMPANIES in the preceding calendar year.
More Definitions of License Income
License Income means any and all consideration actually received by BIOPHYTIS and/or its Affiliates pursuant to any License, including up-front, milestone, success, bonus, maintenance and royalty payments (to the exclusion of payments in relation to patent cost), whether in cash or in the form of shares, options, or other securities obtained from a third party pursuant to the License.
License Income the amounts of royalties and/or lump sum fees effectively received by BAYER from a third party other than an Affiliate as a remuneration for the grant of a sublicense, without transfer of biological materials, under the Licensed Patents and/or the Licensed Know-How.
License Income. . License Income shall mean all amounts received by a Party and/or its Affiliates from Third Parties in connection with or related to the licensing or sublicensing to such Third Parties of rights to Ficlatuzumab, including: (i) all upfront fees, milestone payments and royalties; (ii) transfer pricing amounts paid in respect of Ficlatuzumab supplied to such Third Parties; (iii) investments in securities; and (iv) research and Development funding, but (notwithstanding the foregoing) excluding:
License Income means the gross amount actually received by -------------- either party or its Affiliates for or on account of authorized licenses of rights to any Development Candidate or any Product containing such Development Candidate, including upfront license fees, milestone payments and royalties (the amount of the gross royalties being determined by the terms of the agreement with the authorized licensee, which may take into account factors such as combination sales) without deduction of any kind, but excluding the following: **Certain portions of this Exhibit have been omitted based upon a request for confidential treatment that has been filed with the Commission. The omitted portions have been filed separately with the Commission.
(a) Payments received by either party or its Affiliate solely for performance of research and development, including but not limited to milestone payments for achievement of objectives in research and development, only to the extent that such payments cover the actual cost of the research and development work.
(b) Investments made by a licensee in either party or its Affiliates to the extent that such investments are made at current market value, including but not limited to, any payments or other consideration representing the current market value of shares in such party or its Affiliates.
(c) Payments made to either party or its Affiliate solely to the extent that they cover the actual costs of conducting clinical testing and other activities in connection with obtaining regulatory approval for a Product.
(d) Reimbursed expenses of either party or its Affiliates.
(i) it shall be determined as at the earlier of (a) the date when the investment is made or (b) the day prior to the date when the investment is first publicly disclosed on the Dow Xxxxx News -------------- Wire (the "Determination Date"); (ii) if there is no public market for the ---- party's securities that are being purchased by the licensee, then the current market value shall be determined by that party's Board of Directors in good faith, and if the other party disputes such determination, the current market value shall be determined by an independent investment banker whose fees shall be shared by the parties; (iii) if there is a public market for such party's securities that are being purchased by the licensee, then the current market value shall be determined using the average of the closing price quoted on any exchange on which the securities are listed as published...
License Income means all up-front fees, license signing fees, milestone payments, success fees, royalties and other consideration received by GenSignia or its Affiliates from Licensees on account of the use or sale of Products or grant of a license under the Transferred Patents; provided, however that License Income will not include: (a) amounts paid by such licensee as reimbursement for research and development costs incurred under such license with respect to Products in the event GenSignia collaborates on research and/or development with such a licensee; (b) bona fide loans with market terms; (c) fair market value reimbursement for clinical trial costs and expenses; (d) equity investment in GenSignia at the market value for such equity; (e) amounts paid at fair market value for supplies of Products or other tangible materials, or that are otherwise paid in reimbursement of costs or expenditures, whether incurred before or after the date of the relevant license agreement; (f) upfront fees and milestone payments payable solely for products other than the Products, and (g) withholding taxes or other amounts actually witheld from the amounts received, paid to a governmental authority and not reimbursed by Licensee or any Third Party. License Income shall also not include amounts received in connection with a merger, consolidation or sale of all or substantially all of the business or assets of GenSignia to which this Agreement relates.
License Income means the total gross proceeds (including any royalties, license fees, maintenance fees, or milestone payments), whether consisting of cash or any other form of consideration, received by Gelesis, LLC or one of its Affiliates from any Licensee in consideration of the grant of a license under the Patent Rights, the Improvements, or the Food IP to Exploit any Food Product or any Covered Product that is not orally administered. Notwithstanding the foregoing, License Income shall not include proceeds reasonably and fairly attributable to bona fide (i) debt financing; (ii) equity financing (and conditional equity, such as warrants, convertible debt and the like); (iii) reimbursements of patent prosecution costs and patent maintenance expenses; (iv) reimbursements for the cost of research and/or development services provided at or below commercially reasonable rates.
License Income. License Income shall mean all amounts received by a Party and/or its Affiliates from Third Parties in connection with or related to the licensing or sublicensing to such Third Parties of rights to Ficlatuzumab, including: (i) all upfront fees, milestone payments and royalties; (ii) transfer pricing amounts paid in respect of Ficlatuzumab supplied to such Third Parties; (iii) investments in securities; and (iv) research and Development funding, but (notwithstanding the foregoing) excluding:
(a) transfer pricing amounts equal to such Party’s and/or its Affiliates’ Ficlatuzumab Cost of Goods supplied to such Third Parties;
(b) amounts received by such Party and/or its Affiliates from such Third Parties as the purchase price for such Party’s and/or its Affiliates’ debt or equity securities at prices not in excess of the then-current market price of such securities or, if such securities are not publicly traded, the then-current fair market value of such securities; EXECUTION VERSION
(c) amounts received by such Party and/or its Affiliates for future research and Development activities undertaken for, or in collaboration with, or other services provided to, such Third Parties at rates not to exceed the fair market value of such services, and
(d) amounts received by such Party and/or its Affiliates as reimbursement for costs incurred by such Party and/or its Affiliates after the grant of the license or sublicense in the performance of such Party’s and/or its Affiliates’ obligations thereunder.